Thymoma-associated aplastic anemia initially presenting as bicytopenia: a case report and therapeutic challenges
DOI:
https://doi.org/10.69898/jhtm.35.2025.277391Keywords:
Aplastic anemia, Thymoma, ThymectomyAbstract
Abstract
Aplastic anemia (AA) is a condition characterized by bone marrow failure caused by an immune-mediated response involving cytotoxic T cells. While the etiology of AA is often idiopathic, it can also result from factors such as drugs, toxins and immunologic diseases. Thymomas, tumors located in the anterior mediastinal, are associated with various autoimmune conditions including AA. In this report, we present a case of severe aplastic anemia associated with thymoma, highlighting its clinical presentation, laboratory findings, and histopathologic features.
A 54-year-old Thai woman with a history of dyslipidemia presented with a 1-month history of chronic progressive dyspnea and significant weight loss. On examination, she had physical signs of anemia, petechiae, and a left lung mass. Laboratory tests revealed anemia with reticulocytopenia, thrombocytopenia and a normal total white blood cell count with a reversed neutrophil-to-lymphocyte ratio (absolute neutrophil count 1.4 x 109/L). Bone marrow studies demonstrated hypocellularity with absent megakaryocytes. A computed tomography scan identified a 12.7 cm anterior mediastinal mass, and a biopsy confirmed type AB thymoma. She received a diagnosis of thymoma-associated AA. Despite treatment with cyclosporine, eltrombopag, blood transfusions, and thymectomy, the patient succumbed to a severe infection 4 months after diagnosis.
Downloads
References
Shams Mahdi. The Cytotoxic T Cell Response in Aplastic Anaemia: Mechanisms and Treatments. J Hematol Thrombo Dis. 2024;12:634.
Medinger M, Drexler B, Lengerke C, Passweg J. Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment. Front Oncol. 2018;8:587.
Carter BW, Marom EM, Detterbeck FC. Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol. 2014;9(9 Suppl 2):S102-9.
Zhao J, Bhatnagar V, Ding L, Atay SM, David EA, McFadden PM, et al. A systematic review of paraneoplastic syndromes associated with thymoma: Treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020;160:306-14.e14.
Liozon E, Touati M, Allegraud A, Gachard N, Loustaud V, Vidal E, Bordessoule D. Thymoma-associated pancytopenia: effectiveness of cyclosporine A. Ann Hematol. 1998;77:175-8.
Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 2016;15:82-92.
Gendron N, de Fontbrune FS, Guyard A, Fadlallah J, Chantepie S, D'Aveni M, et al. Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and a review of the literature. Haematologica. 2020;105:e333-e6.
Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M, et al. Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline. Br J Haematol. 2024;204:784-804.
Schoettler ML, Nathan DG. The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited. Hematol Oncol Clin North Am. 2018;32:581-94.
B A, Nangia A, Sharma S, Chandra J. Flowcytometric Cytokine Profiling of T- Lymphocytes in Pediatric Aplastic Anemia. Annals of Pathology and Laboratory Medicine. 2020;7:A152-6.
Hsu CH, Chan JK, Yin CH, Lee CC, Chern CU, Liao CI. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One. 2019;14:e0227197.
Zhao J, Bhatnagar V, Ding L, Atay SM, David EA, McFadden PM, et al. A systematic review of paraneoplastic syndromes associated with thymoma: Treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020;160:306-14 e14.
Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W, et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood. 2000;96:3872-9.
Bacigalupo A. Aplastic anemia: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2007:23-8.
Koizumi K, Nakao S, Haseyama Y, Kato H, Ohi M, Motohara T, et al. Severe aplastic anemia associated with thymic carcinoma and partial recovery of hematopoiesis after thymectomy. Ann Hematol. 2003;82:367-70.
Young NS, Kaufman DW. The epidemiology of acquired aplastic anemia. Haematologica. 2008;93:489-92.
Rivoisy C, Besse B, Girard N, Lioger B, Viallard JF, Lega JC, et al. Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in France. J Thorac Oncol. 2016;11:391-9.
Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M, et al. Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline. British Journal of Haematology. 2024;204:784-804.
Tichelli A, Schrezenmeier H, Socie G, Marsh J, Bacigalupo A, Duhrsen U, et al. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2011;117:4434-41.
Scorsetti M, Leo F, Trama A, D’Angelillo R, Serpico D, Macerelli M, et al. Thymoma and thymic carcinomas. Critical Reviews in Oncology/Hematology. 2016;99:332-50.
Hirunmasuwan M, Numbenjapon T, Niramitmahapanya P, Sinhaseni T, Prayongratana K, Leelasiri A, et al. Successful Treatment of Thymoma-Related Aplastic Anemia with Low-Dose Cyclosporin A: A Case Report and Review of the Literature. J Hematol Transfus Med 2016;26:379-84.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Hematology and Transfusion Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
